Weiss Multi-Strategy Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,922	Closed	-$135K	–	587
2022 Q3	$135K	Sell	17,922 -960	-5%	-$8.31K	﹤0.01%	630
2022 Q2	$190K	Sell	18,882 -996	-5%	-$11.1K	0.01%	616
2022 Q1	$246K	Sell	19,878 -13,576	-41%	-$210K	0.01%	616
2021 Q4	$765K	Sell	33,454 -139	-0.4%	-$3.29K	0.02%	508
2021 Q3	$743K	Buy	33,593 +2,329	+7%	+$37K	0.02%	518
2021 Q2	$405K	Buy	31,264 +1,122	+4%	+$14.3K	0.01%	572
2021 Q1	$391K	Sell	30,142 -67	-0.2%	-$972	0.01%	560
2020 Q4	$418K	Buy	30,209 +10,039	+50%	+$146K	0.01%	589
2020 Q3	$297K	Buy	+20,170	New	+$292K	0.01%	516

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AUPH Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 17,922 shares — an estimated $135K sold.

Weiss Multi-Strategy Advisers first reported a position in AUPH in Q3 2020 and held it in 9 quarters. The position peaked at $765K in Q4 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

Weiss Multi-Strategy Advisers reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 17,922 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $135K.
Weiss Multi-Strategy Advisers first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 9 quarters.
Weiss Multi-Strategy Advisers's Aurinia Pharmaceuticals position peaked at $765K in Q4 2021.
191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.